Sudden death in young people during competitive sports is devastating and counterintuitive, but fortunately a relatively uncommon event.1 Such athletes epitomize the healthiest and most vigorous element of society, voluntarily participating in activities that the community intuitively considers benign and free of significant mortality risk. Screening of young, healthy, general populations to detect cardiovascular diseases responsible for these deaths has been of intense interest in the physician community and general public at the intersection of cardiology, pediatrics, and family practice with public health policy, and largely involving a variety of complex and relatively uncommon genetic disorders or congenital heart diseases responsible for these sudden and unexpected events.
Barry J. Maron, Bo Gregers Winkel, Jacob Tfelt-Hansen. Perspectives on Cardiovascular Screening. JAMA. 2015;313(1):31–32. doi:10.1001/jama.2014.16253